217 related articles for article (PubMed ID: 38273052)
21. Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
Zhou X; Su J; Zhu L; Zhang G
Helicobacter; 2014 Jun; 19(3):174-81. PubMed ID: 24628843
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome Analysis of the Inhibitory Effect of Astaxanthin on
Kim SH; Kim H
Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32679742
[No Abstract] [Full Text] [Related]
23. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
[TBL] [Abstract][Full Text] [Related]
24. The correlation between lncRNAs and Helicobacter pylori in gastric cancer.
Dastmalchi N; Khojasteh SMB; Nargesi MM; Safaralizadeh R
Pathog Dis; 2019 Dec; 77(9):. PubMed ID: 31981356
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
27. Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.
Toyoda T; Tsukamoto T; Yamamoto M; Ban H; Saito N; Takasu S; Shi L; Saito A; Ito S; Yamamura Y; Nishikawa A; Ogawa K; Tanaka T; Tatematsu M
BMC Gastroenterol; 2013 Jul; 13():122. PubMed ID: 23899160
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway.
Guo Y; Zhang T; Shi Y; Zhang J; Li M; Lu F; Zhang J; Chen X; Ding S
Helicobacter; 2020 Feb; 25(1):e12665. PubMed ID: 31657090
[TBL] [Abstract][Full Text] [Related]
29. Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection.
Chang H; Kim N; Park JH; Nam RH; Choi YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JM; Lee DH
Gut Liver; 2015 Mar; 9(2):188-96. PubMed ID: 25167801
[TBL] [Abstract][Full Text] [Related]
30. Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.
Soutto M; Romero-Gallo J; Krishna U; Piazuelo MB; Washington MK; Belkhiri A; Peek RM; El-Rifai W
Oncotarget; 2015 Jul; 6(20):17911-22. PubMed ID: 25980439
[TBL] [Abstract][Full Text] [Related]
31. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
[TBL] [Abstract][Full Text] [Related]
32. Expression Profile of miRNA-17-3p and miRNA-17-5p Genes in Gastric Cancer Patients with Helicobacter pylori Infection.
Khayam N; Nejad HR; Ashrafi F; Abolhassani M
J Gastrointest Cancer; 2021 Mar; 52(1):130-137. PubMed ID: 31997281
[TBL] [Abstract][Full Text] [Related]
33. Carcinogenic
Noto JM; Rose KL; Hachey AJ; Delgado AG; Romero-Gallo J; Wroblewski LE; Schneider BG; Shah SC; Cover TL; Wilson KT; Israel DA; Roa JC; Schey KL; Zavros Y; Piazuelo MB; Peek RM
Mol Cell Proteomics; 2019 Feb; 18(2):352-371. PubMed ID: 30455363
[No Abstract] [Full Text] [Related]
34. CDX1 Expression Induced by CagA-Expressing
Choi SI; Yoon C; Park MR; Lee D; Kook MC; Lin JX; Kang JH; Ashktorab H; Smoot DT; Yoon SS; Cho SJ
Mol Cancer Res; 2019 Nov; 17(11):2169-2183. PubMed ID: 31416838
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior.
Huang WT; Kuo SH; Cheng AL; Lin CW
Mod Pathol; 2014 Aug; 27(8):1116-25. PubMed ID: 24390222
[TBL] [Abstract][Full Text] [Related]
36. Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates.
Liu H; Merrell DS; Semino-Mora C; Goldman M; Rahman A; Mog S; Dubois A
Gastroenterology; 2009 Oct; 137(4):1367-79.e1-6. PubMed ID: 19622359
[TBL] [Abstract][Full Text] [Related]
37. L-Plastin Promotes Gastric Cancer Growth and Metastasis in a
Teng YS; Chen WY; Yan ZB; Lv YP; Liu YG; Mao FY; Zhao YL; Peng LS; Cheng P; Duan MB; Chen W; Wang Y; Luo P; Zou QM; Chen J; Zhuang Y
Mol Cancer Res; 2021 Jun; 19(6):968-978. PubMed ID: 33771880
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.
Figueiredo C; Machado JC; Pharoah P; Seruca R; Sousa S; Carvalho R; Capelinha AF; Quint W; Caldas C; van Doorn LJ; Carneiro F; Sobrinho-Simões M
J Natl Cancer Inst; 2002 Nov; 94(22):1680-7. PubMed ID: 12441323
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.
Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM
World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876
[TBL] [Abstract][Full Text] [Related]
40.
Yang JS; Kang CY; Su CH; Chen CJ; Chiu YJ; Hsu YM
Anticancer Res; 2022 Jan; 42(1):531-546. PubMed ID: 34969763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
